Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy -- a survey of 427 patients.

@article{Tsavaris2002CardiotoxicityFD,
  title={Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy -- a survey of 427 patients.},
  author={Nicolas B. Tsavaris and Christos Kosmas and Maria Vadiaka and Michalis Efremidis and Andreas Zinelis and Dimitris Beldecos and Dimitris Sakelariou and Christos Koufos and George Stamatelos},
  journal={Medical science monitor : international medical journal of experimental and clinical research},
  year={2002},
  volume={8 6},
  pages={PI51-7}
}
BACKGROUND Although cardiotoxicity associated with 5-Fluorouracil (5-FU) administration is infrequent, there are case reports of acute coronary syndromes. We report on patients undergoing 5-FU chemotherapy who developed cardiac symptoms during its administration. MATERIAL/METHODS In patients receiving 5-FU who experienced cardiac-related symptoms, ECG and serum cardiac enzyme determination were performed. If cardiotoxicity was detected, 5-FU infusion was interrupted, and the patients received… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 22 extracted citations

Similar Papers

Loading similar papers…